APA (7th ed.) Citation

PW, K., CB, S., F, R., T, B., N, H., P, L., . . . MD, T. (2025). Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer. JCO precision oncology, 9, e2500286. https://doi.org/10.1200/PO-25-00286

Chicago Style (17th ed.) Citation

PW, Ketch, et al. "Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer." JCO Precision Oncology 9 (2025): e2500286. https://doi.org/10.1200/PO-25-00286.

MLA (9th ed.) Citation

PW, Ketch, et al. "Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer." JCO Precision Oncology, vol. 9, 2025, p. e2500286, https://doi.org/10.1200/PO-25-00286.